A smart inhaler is also recognized as connected inhaler and sensors. Smart inhalers are specific devices, used to deliver various medications through the inhalation. Some drugs used in the inhalers include glucocorticoids, insulin, anti-cholinergic, and beta-agonists for treatment & prevention of the respiratory diseases for instance asthma and chronic obstructive pulmonary diseases (COPD). The data captured by these smart inhalers is shared with the patients & healthcare professionals to track their usage. The monitored data is then shared using Bluetooth technology for their mobile applications through a platform like Hailie. A Hailie system is a special type of sensor that connects to the inhaler and shares data on the control platform to monitor the health and compliance rate.
As per analysis, “Smart
Inhalers Market: Current Analysis and Forecast (2021-2028)” the key
companies operating in the global smart inhalers market include Teva
Pharmaceuticals Industries Ltd., Cohero Health Inc., Boehringer Ingelheim,
Vectura Group, Adherium Limited, Novartis, Omron Corp., 3M, Glaxosmithkline,
Astrazeneca and among others. Well-known manufacturers focus on partnering with
digital & software players to serve the target audience. In addition, these
partnerships also facilitate the manufacturers launch their products more
profitably as well as improve their distribution channels.
Growth in adoption of smart
inhalers for proper management of COPD & asthma, followed by rise in
levels of pollution and increase in acceptance towards digital healthcare
equipment are some major factors, which are responsible for growth of the smart
inhalers market. However, high cost of asthma and COPD treatment and misusing
data & data privacy may impact the market. Moreover, increase in research
& development (R&D) activities, growth in focus towards advanced
treatment protocols and increase in modernization & technological
advancements in the healthcare sector are leading opportunities for market.
Based on regional analysis, the North-America is a leading region
in global smart inhalers market
owing to increase in prevalence of COPD & asthma, rise in per capita income
and growth in population susceptible to indoor air pollutants across the
region. The Asia-Pacific and Europe regions are estimated to witness higher
growth rate due to growth in number of product development coupled with growth
in healthcare expenditure over the forecast period. It is predicted that future
of the global market will be bright as a result of rise in prevalence of
respiratory diseases coupled with increase in collaboration between pharma and
digital health companies during the forecast period.
For More Information, refer to
below link:-
Contact
Us:-
Ken
Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249
